MRI Response Assessment in Glioblastoma Patients Treated with Dendritic-Cell-Based Immunotherapy.

Autor: Heugenhauser J; Department of Neurology, Medical University of Innsbruck, 6020 Innsbruck, Austria., Galijasevic M; Department of Neuroradiology, Medical University of Innsbruck, 6020 Innsbruck, Austria.; Neuroimaging Core Facility, Medical University of Innsbruck, 6020 Innsbruck, Austria., Mangesius S; Department of Neuroradiology, Medical University of Innsbruck, 6020 Innsbruck, Austria.; Neuroimaging Core Facility, Medical University of Innsbruck, 6020 Innsbruck, Austria., Goebel G; Department of Medical Statistics, Informatics and Health Economics, Medical University of Innsbruck, 6020 Innsbruck, Austria., Buchroithner J; Department of Neurosurgery, Johannes Kepler University, 4020 Linz, Austria., Erhart F; Department of Neurosurgery, Medical University of Vienna, 1090 Vienna, Austria.; Department of Neurology, Medical University of Vienna, 1090 Vienna, Austria., Pichler J; Department of Internal Medicine and Neurooncology, Johannes Kepler University, 4020 Linz, Austria., Widhalm G; Department of Neurosurgery, Medical University of Vienna, 1090 Vienna, Austria., Stockhammer G; Department of Neurology, Medical University of Innsbruck, 6020 Innsbruck, Austria., Iglseder S; Department of Neurology, Medical University of Innsbruck, 6020 Innsbruck, Austria., Freyschlag CF; Department of Neurosurgery, Medical University of Innsbruck, 6020 Innsbruck, Austria., Oberndorfer S; Department of Neurology, Landsteiner Private University, 3100 St. Pölten, Austria., Bordihn K; Department of Neurosurgery, Paracelsus Private Medical University, 5020 Salzburg, Austria., von Campe G; Department of Neurosurgery, Medical University of Graz, 8036 Graz, Austria., Czech T; Department of Neurosurgery, Medical University of Vienna, 1090 Vienna, Austria., Surböck B; Department of Neurology, Klinik Favoriten, Wiener Gesundheitsverbund, 1100 Vienna, Austria., Urbanic Purkart T; Department of General Neurology and Neuroradiology, Vascular and Interventional Radiology, Medical University of Graz, 8036 Graz, Austria., Marosi C; Clinical Division of Medical Oncology, Department for Internal Medicine I, Medical University of Vienna, 1090 Vienna, Austria., Felzmann T; Activartis Biotech GmbH, 1160 Vienna, Austria., Nowosielski M; Department of Neurology, Medical University of Innsbruck, 6020 Innsbruck, Austria.

Publikováno v: Cancers [Cancers (Basel)] 2022 Mar 20; Vol. 14 (6). Date of Electronic Publication: 2022 Mar 20.

Towards integrating imaging and immunology in glioblastoma: mapping blood immune system metrics to tumor magnetic resonance image data.

Autor: Heugenhauser, Johanna¹ (AUTHOR), Visus, Carmen² (AUTHOR), Buchroithner, Johanna³ (AUTHOR), Marosi, Christine⁴ (AUTHOR), Rössler, Karl⁵ (AUTHOR), Felzmann, Thomas⁶ (AUTHOR), Widhalm, Georg⁵ (AUTHOR), Iglseder, Sarah¹ (AUTHOR), Nowosielski, Martha¹ (AUTHOR), Erhart, Friedrich⁵ (AUTHOR) friedrich.erhart@meduniwien.ac.at

Publikováno v: Acta Neuropathologica Communications. 11/27/2024, Vol. 12 Issue 1, p1-13. 13p.

Audencel Immunotherapy Based on Dendritic Cells Has No Effect on Overall and Progression-Free Survival in Newly Diagnosed Glioblastoma: A Phase II Randomized Trial.

Autor: Buchroithner J; University Clinic for Neurosurgery, Kepler University Hospital, Johannes Kepler University, Wagner-Jauregg-Weg 15, 4020 Linz, Austria. johanna.buchroithner@kepleruniklinikum.at., Erhart F; Department of Neurosurgery, Medical University of Vienna, Währinger Gürtel 18-20, 1090 Vienna, Austria. friedrich.erhart@meduniwien.ac.at.; Institute of Neurology, Medical University of Vienna, Währinger Gürtel 18-20, 1090 Vienna, Austria. friedrich.erhart@meduniwien.ac.at., Pichler J; Department of Internal Medicine and Neurooncology, Kepler University Hospital, Johannes Kepler University, Wagner-Jauregg-Weg 15, 4020 Linz, Austria. Josef.Pichler@kepleruniklinikum.at., Widhalm G; Department of Neurosurgery, Medical University of Vienna, Währinger Gürtel 18-20, 1090 Vienna, Austria. georg.widhalm@meduniwien.ac.at., Preusser M; Clinical Division of Medical Oncology, Department for Internal Medicine I, Medical University of Vienna, Währinger Gürtel 18-20, 1090 Vienna, Austria. Matthias.preusser@meduniwien.ac.at., Stockhammer G; Department of Neurology, Medical University of Innsbruck, Christoph-Probst-Platz 1, Innrain 52, 6020 Innsbruck, Austria. guenther.stockhammer@i-med.ac.at., Nowosielski M; Department of Neurology, Medical University of Innsbruck, Christoph-Probst-Platz 1, Innrain 52, 6020 Innsbruck, Austria. Martha.Nowosielski@i-med.ac.at., Iglseder S; Department of Neurology, Medical University of Innsbruck, Christoph-Probst-Platz 1, Innrain 52, 6020 Innsbruck, Austria. sarah.iglseder@tirol-kliniken.at., Freyschlag CF; Department of Neurosurgery, Medical University of Innsbruck, Christoph-Probst-Platz 1, Innrain 52, 6020 Innsbruck, Austria. christian.freyschlag@i-med.ac.at., Oberndorfer S; Department of Neurology, University Clinic St. Pölten, Karl Landsteiner Privat Universität, Dunant-Platz 1, 3100 St. Pölten, Austria. Stefan.Oberndorfer@stpoelten.lknoe.at., Bordihn K; Department of Neurosurgery, Landeskrankenhaus Salzburg, University Clinic of the Paracelsus Private Medical University, Müllner Hauptstraße 48, 5020 Salzburg, Austria. k.bordihn@salk.at., von Campe G; Department of Neurosurgery, Medical University of Graz, Auenbruggerplatz 29, 8036 Graz, Austria. gord.von-campe@medunigraz.at., Hoffermann M; Department of Neurosurgery, Medical University of Graz, Auenbruggerplatz 29, 8036 Graz, Austria. markus.hoffermann@lkhf.at., Ruckser R; Department of Internal Medicine 2, Donauspital, Langobardenstraße 122, 1220 Vienna, Austria. reinhard.ruckser@aon.at., Rössler K; Department of Neurosurgery, Friedrich-Alexander-Universität Erlangen-Nürnberg, Schwabachanlage 6, 91054 Erlangen, Germany. Karl.roessler@uk.erlangen.de., Spiegl-Kreinecker S; University Clinic for Neurosurgery, Kepler University Hospital, Johannes Kepler University, Wagner-Jauregg-Weg 15, 4020 Linz, Austria. Sabine.Spiegl-Kreinecker@kepleruniklinikum.at., Fischer MB; Department of Blood Group Serology and Transfusion Medicine, Medical University of Vienna, Währinger Gürtel 18-20, 1090 Vienna, Austria. michael.b.fischer@meduniwien.ac.at., Czech T; Department of Neurosurgery, Medical University of Vienna, Währinger Gürtel 18-20, 1090 Vienna, Austria. thomas.czech@meduniwien.ac.at., Visus C; Activartis Biotech GmbH, Wilhelminenstraße 91/IIf, 1160 Vienna, Austria. maria-carmen.visus-miguel@aoporphan.com., Krumpl G; Activartis Biotech GmbH, Wilhelminenstraße 91/IIf, 1160 Vienna, Austria. g.krumpl@medresnet.com., Felzmann T; Activartis Biotech GmbH, Wilhelminenstraße 91/IIf, 1160 Vienna, Austria. tfelzm@gmail.com., Marosi C; Clinical Division of Medical Oncology, Department for Internal Medicine I, Medical University of Vienna, Währinger Gürtel 18-20, 1090 Vienna, Austria. christine.marosi@meduniwien.ac.at.

Publikováno v: Cancers [Cancers (Basel)] 2018 Oct 05; Vol. 10 (10). Date of Electronic Publication: 2018 Oct 05.

Vascular endothelia growth factor targeted therapy may improve the effect of dendritic cell-based cancer immune therapy.

Autor: Buchroithner J, Pichler J, Marosi C, Widhalm G, Seiz-Rosenhagen M, Novosielski M, Oberndorfer S, Ruckser R, Rössler K, Azizi A, von Campe G, Bordihn K, Felzmann T

Publikováno v: International journal of clinical pharmacology and therapeutics [Int J Clin Pharmacol Ther] 2014 Jan; Vol. 52 (1), pp. 76-7.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.